MLYS Competitors & Alternatives
Compare Mineralys Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MLYS
Main Stock$25.74
Tradestie Score
52
Market Cap
$3.09B
Analyst Upside
+90.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.35
|
$2.40B | - | 56 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.84
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.09
|
$2.35B | - | 47 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.24
|
$2.34B | - | 47 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.22
|
$2.33B | - | 60 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$30.66
|
$2.33B | - | 50 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.17
|
$2.23B | - | 54 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$23.44
|
$2.22B | - | 59 | Compare |
More MLYS Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry